Physician profile
Tucker James Harrison
NPI 1396004636
$19,498.25
in general payments reported to CMS, 2019-2025
31 companies · $2,803 in 2025
The $2,803 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,504 · 2020: $383 · 2021: $1,888 · 2022: $4,149 · 2023: $1,967 · 2024: $5,804 · 2025: $2,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,494 · Travel and Lodging: $3,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,493.65 |
| Travel and Lodging | $3,080.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $4,918.16 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $4,167.98 | 2022-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $2,364.30 | 2019-2025 | General - Balloon Catheters, Peripheral Rotalink Plus, Ekosonic |
| Abiomed | $2,106.45 | 2022-2025 | Impella |
| Stryker Corporation | $1,164.25 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Shockwave Medical, INC | $1,064.41 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $757.42 | 2020-2024 | Mitraclip, Confirm Rx, Assurity |
| Cardiovascular Systems INC. | $653.97 | 2019-2022 | |
| Imperative Care, INC | $360.93 | 2024-2025 | Symphony Catheter |
| Angiodynamics, INC. | $317.35 | 2021-2025 | Alphavac, Venacure 1470 Pro |
| Bard Peripheral Vascular, INC. | $306.17 | 2022-2024 | Venclose Maven Catheter |
| Surmodics, INC. | $299.99 | 2023-2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Novartis Pharmaceuticals Corporation | $224.51 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $147.72 | 2023 | Optimizer |
| Amgen INC. | $141.47 | 2021-2025 | Repatha, Repatha |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.61 | 2022-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.71 | 2022-2023 | Jardiance |
| Silk Road Medical, INC. | $52.10 | 2022 | |
| Novo Nordisk INC | $38.95 | 2023 | Ozempic, Rybelsus |
| Atricure, INC. | $38.08 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $35.44 | 2024 | Arcalyst |
| Philips North America LLC | $35.43 | 2024-2025 | Mcot, (Ck4) Mcot |
| E.R. Squibb & Sons, L.L.C. | $28.20 | 2021 | |
| Mozarc Medical US LLC | $24.63 | 2025 | Palindrome |
| Kestra Medical Technology Services, INC. | $22.53 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $20.60 | 2023 | Andexxa |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Pfizer INC. | $19.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.46 | 2021 | |
| Bridgebio Pharma, INC. | $16.30 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $15.05 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tucker Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.